JAMA: Weight-Loss GLP-1 Prescriptions Fell 84% in Four States That Ended Medicaid Coverage on January 1
University of Pittsburgh researchers found that in California, New Hampshire, Pennsylvania, and South Carolina, Medicaid prescriptions for GLP-1s approved for weight loss fell from 2,914 to 421 per 100,000 beneficiaries between late 2025 and early 2026, versus 3,006 to 2,758 in 10 states that kept coverage. Pennsylvania's drop was 95.5%. The authors estimate 175,500 to 526,600 fewer beneficiaries may have filled prescriptions, and they saw no significant shift to diabetes-approved GLP-1s.